Lexeo Therapeutics, Inc. (LXEO)
Latest LXEO Insider Trades
- Louis Edward Tamayo - OfficerOpen-market sale$20K
Richard Nolan Townsend - Officer
About Lexeo Therapeutics, Inc. (LXEO)
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
- NEW YORK, NY
- 59
- 2023
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 7 | 66,326 | $300K |
| Grant or award | 11 | 391,060 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
LXEO Insider Transactions (Form 4)
3649 Form 4 filings on record, the earliest from Oct 15, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jose Manuel Otero - Officer | Grant or award | Common Stock | 5,940 |
Recent LXEO Form 8-K Filings
5Recent LXEO Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Otero Jose Manuel | Officer | 1,304 | $6K | View on EDGAR | |
| Townsend Richard Nolan | Officer, Director |
LXEO Insider Trading - FAQ
What is the latest insider trade for LXEO?
Lexeo Therapeutics, Inc. (LXEO) had 14 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for LXEO runs to 49 Form 4 filings, the earliest from 2024-10-15. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying LXEO stock?
No insider purchases of LXEO were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling LXEO stock?
7 insider sales of LXEO were filed in the last 90 days, totaling $300K.
Where can I see LXEO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks LXEO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow LXEO insider buys?
Create a free InsiderAlpha account and press Watch on this page to add LXEO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Louis Edward Tamayo view on EDGAR
- - Richard Nolan Townsend view on EDGAR
- - Jose Manuel Otero view on EDGAR
- - Louis Edward Tamayo view on EDGAR
- - Jose Manuel Otero view on EDGAR
- - Narinder Pal Bhalla view on EDGAR
- - Richard Nolan Townsend view on EDGAR
- - Steven Altschuler view on EDGAR
- - Mette Kirstine Agger view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where LXEO's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track LXEO insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
